当前位置: X-MOL 学术J. Pediat. Inf. Dis. Soc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.
Journal of the Pediatric Infectious Diseases Society ( IF 3.2 ) Pub Date : 2022-10-25 , DOI: 10.1093/jpids/piac076
Cristina Epalza 1, 2, 3, 4 , Luis Prieto-Tato 1, 2, 3, 4 , Rosa Pino 5 , Paula Escartín-Paredes 1 , Inés Leoz 6 , Carlos Grasa 7, 8 , Ana Vivanco-Allende 9 , Jacques G Rivière 10, 11, 12 , Jaume Carrasco-Colom 13 , Olatz Villate 14 , Victoria Fumadó 15 , Concepción Hermoso-Ibañez 1 , Blanca Herrero 16 , David Aguilera-Alonso 2, 3, 4, 17, 18 , Alfredo Tagarro 2, 3, 4, 19 , Cinta Moraleda 1, 2, 3, 4 ,
Affiliation  

In this cohort of 42 adolescents with a previous multisystem inflammatory syndrome (MIS-C) diagnosis, 32 (76.2%) were vaccinated with COVID-19 vaccines, with a low incidence of relevant adverse events. More importantly, no new MIS-C or myocarditis occurred after a median of 10 weeks (range 5.3-19.7) post-vaccination.

中文翻译:

西班牙儿童多系统炎症综合征 (MIS-C) 后 COVID-19 疫苗接种的安全性和可接受性。

在这组 42 名先前诊断为多系统炎症综合征 (MIS-C) 的青少年中,32 名 (76.2%) 接种了 COVID-19 疫苗,相关不良事件的发生率较低。更重要的是,在接种疫苗后中位 10 周(范围 5.3-19.7)后,没有出现新的 MIS-C 或心肌炎。
更新日期:2022-07-29
down
wechat
bug